Navigation Links
Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine
Date:12/8/2008

at Phosphagenics said; "While we have previously demonstrated the penetrative power of our TPM technology, the success of this trial validates the versatility and precision of Phosphagenics' drug delivery platform in humans. We view this as a major achievement for our company and look forward to moving ahead with further clinical trials."

The open label, single centre study was conducted at the Centre for Pharmaceutical Research, University of South Australia, under the guidance of Principal Investigator Dr. David Foster. 11 healthy adult volunteers enrolled in the bioavailability trial of dermal and systemic pharmacokinetics, which incorporated secondary endpoints of safety and tolerability.

APPENDIX AND NOTES TO EDITORS

About Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC.

For
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
3. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
4. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
5. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
6. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
7. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
8. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
9. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
10. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
11. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Mr Minoru Yoshizumi , President of ... , is pleased to announce the release of EggQus, ... the European Radiology Congress (ECR). Delegates will have the ... Medical Systems booth 323, Expo C.      ... (Photo: http://photos.prnewswire.com/prnh/20150305/732754-b ) , , ...
(Date:3/5/2015)... March 5, 2015  MGC Diagnostics Corporation (NASDAQ: ... company, today reported financial results for the first ... 2015 first quarter domestic equipment, supplies and accessories ... $3.7 million in the 2014 first quarter.  During ... or $338,000 in revenue, compared to 14 accounts, ...
(Date:3/4/2015)... Holdings, Inc. (NYSE: HRC ) announced today ... to its Board of Directors.  She most recently served ... as President of Covidien,s Vascular Therapies Division from 2012 to ... 2012. Ms. Enxing Seng joined Covidien in ... she was a founding member and executive officer responsible ...
Breaking Medicine Technology:Hitachi Aloka Medical, Ltd. Introduces EggQus AOS 100E - a Compact and Lightweight Ultrasound Bone Densitometry System 2Hitachi Aloka Medical, Ltd. Introduces EggQus AOS 100E - a Compact and Lightweight Ultrasound Bone Densitometry System 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2
... , BETHESDA, Md. , June 14 ... American provider of Western healthcare,products and services in the People,s Republic ... year ended March 31, 2010 . , , ... fiscal year 2010, -- Operating income up 76.6% year ...
... ,, NEW YORK , June 12 ... continues its promotion of body fat monitors, and,children can bring it home ... , , ... leading online home medical,equipment suppliers. For the coming Father,s Day , ...
Cached Medicine Technology:Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 11Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 12Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 13Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 14Father's Day Promotion of Body Fat Monitors Continues on Medicalequipmentpro.com 2Father's Day Promotion of Body Fat Monitors Continues on Medicalequipmentpro.com 3Father's Day Promotion of Body Fat Monitors Continues on Medicalequipmentpro.com 4
(Date:3/5/2015)... (PRWEB) March 05, 2015 The recent ... weight loss promises is alarming, with more and more ... without an actual prescription, making it easy for more ... simply take their money and endanger their health. The ... before purchasing prescription online diet pills: , 1.    Where are ...
(Date:3/5/2015)... ATLANTA, GA (PRWEB) March 05, 2015 ... networking and relationship-marketing firm, honored finalists and winners ... Southeast Executive Forum and Awards Gala at the ... Chronis, chief security officer for EarthLink, was selected ... Award winner for the ISE® Southeast Region. Pete ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Considering egg ... fertility practice, is holding an informational event ... proactively plan for future families with egg freezing. , ... Plaza, 3500 Peachtree Rd, Atlanta, GA, Time: 5:30 - ... but RSVP required. Register here ! , In ...
(Date:3/5/2015)... 05, 2015 What makes a legend? In ... it’s almost 50 years of exceptional courtroom performance, championing big ... his five decades of brilliant service, the Dallas Bar Association ... Schmidt will be honored at a luncheon on Tuesday, April ... Ross Avenue. Other award nominees for this year are Bob ...
(Date:3/5/2015)... Developers and plugin specialists of Final ... transition pack entitled TranSlice Wipe for FCPX. , “TranSlice ... ease while maintaining a professional look,” Said Christina Austin, ... time saver with transitions our users will love.” , ... screen transitions with a new style. TranSlice Wipe allows ...
Breaking Medicine News(10 mins):Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 2Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 4Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2Health News:Pixel Film Studios Released TranSlice Wipe Exclusively for Final Cut Pro X Editors 2
... has been awarded to researchers at Queen,s to help ... likely to smoke than the general population. , It ... the scientists discover improved treatments for nicotine dependence - ... death from smoking-related diseases - as well as treatments ...
... A minimally invasive treatment for a common cause of male infertility ... new study published in the August issue of Radiology. , ... ... minimally invasive treatment for a common cause of male infertility can ...
... application of a pain-relieving gel may reduce the breast ... the results of a clinical trial published in the ... have something that we know reduces discomfort with screening ... the trial,s principal investigator, Colleen Lambertz, F.N.P., a nurse ...
... removed than men, study shows , , MONDAY, July 21 (HealthDay ... with their decision, women are much more likely than men ... , The study authors noted that the gender difference might ... more social stigma and negative comments as a result of ...
... -- Researchers from Duke University, the University of Cincinnati ... hoping to find a geographical pattern to help explain ... disease amyotrophic lateral sclerosis (ALS) at twice the normal ... layering military records of troop locations onto Gulf-area maps, ...
... kill cells on organ,s surface, spare surrounding tissue ... are being recruited for a clinical trial of a ... a cancer of the lung,s lining that,s almost always ... treatment is to remove the affected lung. , "Current ...
Cached Medicine News:Health News:Grant will help patients with schizophrenia who smoke 2Health News:Minimally Invasive Treatment Improves Male Fertility 2Health News:Minimally Invasive Treatment Improves Male Fertility 3Health News:Over-the-counter anesthetic gel puts the squeeze on mammogram pain 2Health News:Women More Likely to Have Second Thoughts on Tattoos 2Health News:Women More Likely to Have Second Thoughts on Tattoos 3Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 2Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 3Health News:Lung Cancer Trial Targets Asbestos-Related Disease 2
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Facilitates intubation of tracheal tubes....
SunGlide™ Stylette - Green Adult. Use in 7.0 to 10mm tubes. 25/box....
Medicine Products: